2022
DOI: 10.1016/j.jacbts.2022.02.007
|View full text |Cite
|
Sign up to set email alerts
|

Audicor Remote Patient Monitoring

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 5 publications
0
1
0
Order By: Relevance
“…Audicor (Inovise Medical) remote patient monitoring is a noninvasive recording device that measures cardiac acoustic biomarkers (CABs) such as electromechanical activation time (also known as EMAT, or the time from QRS onset to the first heart sound interval) and the third heart sound strength using automated acoustic cardiography [38]. CABs are analyzed using a machine learning algorithm to ultimately predict progression of HF.…”
Section: Wearable Devicesmentioning
confidence: 99%
“…Audicor (Inovise Medical) remote patient monitoring is a noninvasive recording device that measures cardiac acoustic biomarkers (CABs) such as electromechanical activation time (also known as EMAT, or the time from QRS onset to the first heart sound interval) and the third heart sound strength using automated acoustic cardiography [38]. CABs are analyzed using a machine learning algorithm to ultimately predict progression of HF.…”
Section: Wearable Devicesmentioning
confidence: 99%
“…7 Recent advances in digital technology have enabled small and handy monitoring devices, including digital stethoscopes and ECGs, and cloud-based systems where personal health information can be pooled together. [8][9][10] Previously, we showed the possibility that changes in heart sounds detected using a portable digital stethoscope may re ect HF condition changes. 11 Other studies have also reported that changes in heart sounds were associated with increased left ventricular lling pressure and left ventricular dysfunction.…”
Section: Introductionmentioning
confidence: 99%